APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Anesthetics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Opioid Anesthetics Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchOpioid Anesthetics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Anesthetics Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Opioid Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Anesthetics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Anesthetics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Opioid Anesthetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Opioid Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Opioid Anesthetics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Opioid Anesthetics market include Janssen, Teva, Sandoz, Merck, Mylan, Abbvie, Sterimax, Grunenthal and Akorn, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Anesthetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Anesthetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Anesthetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Anesthetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Anesthetics Segment by Company

Janssen

Teva

Sandoz

Merck

Mylan

Abbvie

Sterimax

Grunenthal

Akorn

Opioid Anesthetics Segment by Type

Oral

Injection

Opioid Anesthetics Segment by Application

Hospital

Clinic

Opioid Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Opioid Anesthetics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Opioid Anesthetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Opioid Anesthetics significant trends, drivers, influence factors in global and regions.

6. To analyze Opioid Anesthetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Anesthetics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Anesthetics industry.

Chapter 3: Detailed analysis of Opioid Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Opioid Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Opioid Anesthetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Opioid Anesthetics Industry Trends Table 2. Opioid Anesthetics Industry Drivers Table 3. Opioid Anesthetics Industry Opportunities and Challenges Table 4. Opioid Anesthetics Industry Restraints Table 5. Global Opioid Anesthetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Opioid Anesthetics Revenue Share by Company (2021-2026) Table 7. Global Opioid Anesthetics Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Opioid Anesthetics Sales Volume Share by Company (2021-2026) Table 9. Global Opioid Anesthetics Average Price (US$/ton) of Company (2021-2026) Table 10. Global Opioid Anesthetics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Opioid Anesthetics Key Company Manufacturing Base & Headquarters Table 12. Global Opioid Anesthetics Company, Product Type & Application Table 13. Global Opioid Anesthetics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Anesthetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injection Table 19. Global Opioid Anesthetics Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global Opioid Anesthetics Sales Volume by Type (2021-2026) & (k tons) Table 21. Global Opioid Anesthetics Sales Volume by Type (2027-2032) & (k tons) Table 22. Global Opioid Anesthetics Sales Volume Share by Type (2021-2026) Table 23. Global Opioid Anesthetics Sales Volume Share by Type (2027-2032) Table 24. Global Opioid Anesthetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Opioid Anesthetics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Opioid Anesthetics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Opioid Anesthetics Sales Value Share by Type (2021-2026) Table 28. Global Opioid Anesthetics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Opioid Anesthetics Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 32. Global Opioid Anesthetics Sales Volume by Application (2021-2026) & (k tons) Table 33. Global Opioid Anesthetics Sales Volume by Application (2027-2032) & (k tons) Table 34. Global Opioid Anesthetics Sales Volume Share by Application (2021-2026) Table 35. Global Opioid Anesthetics Sales Volume Share by Application (2027-2032) Table 36. Global Opioid Anesthetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Opioid Anesthetics Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Opioid Anesthetics Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Opioid Anesthetics Sales Value Share by Application (2021-2026) Table 40. Global Opioid Anesthetics Sales Value Share by Application (2027-2032) Table 41. Global Opioid Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 42. Global Opioid Anesthetics Sales by Region (2021-2026) & (k tons) Table 43. Global Opioid Anesthetics Sales Market Share by Region (2021-2026) Table 44. Global Opioid Anesthetics Sales by Region (2027-2032) & (k tons) Table 45. Global Opioid Anesthetics Sales Market Share by Region (2027-2032) Table 46. Global Opioid Anesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Opioid Anesthetics Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Opioid Anesthetics Sales Value Share by Region (2021-2026) Table 49. Global Opioid Anesthetics Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Opioid Anesthetics Sales Value Share by Region (2027-2032) Table 51. Global Opioid Anesthetics Market Average Price (US$/ton) by Region (2021-2026) Table 52. Global Opioid Anesthetics Market Average Price (US$/ton) by Region (2027-2032) Table 53. Global Opioid Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Global Opioid Anesthetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Opioid Anesthetics Sales by Country (2021-2026) & (k tons) Table 56. Global Opioid Anesthetics Sales Market Share by Country (2021-2026) Table 57. Global Opioid Anesthetics Sales by Country (2027-2032) & (k tons) Table 58. Global Opioid Anesthetics Sales Market Share by Country (2027-2032) Table 59. Global Opioid Anesthetics Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Opioid Anesthetics Sales Value Market Share by Country (2021-2026) Table 61. Global Opioid Anesthetics Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Opioid Anesthetics Sales Value Market Share by Country (2027-2032) Table 63. Janssen Company Information Table 64. Janssen Business Overview Table 65. Janssen Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Janssen Opioid Anesthetics Product Portfolio Table 67. Janssen Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Teva Opioid Anesthetics Product Portfolio Table 72. Teva Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Sandoz Opioid Anesthetics Product Portfolio Table 77. Sandoz Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Merck Opioid Anesthetics Product Portfolio Table 82. Merck Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Mylan Opioid Anesthetics Product Portfolio Table 87. Mylan Recent Development Table 88. Abbvie Company Information Table 89. Abbvie Business Overview Table 90. Abbvie Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Abbvie Opioid Anesthetics Product Portfolio Table 92. Abbvie Recent Development Table 93. Sterimax Company Information Table 94. Sterimax Business Overview Table 95. Sterimax Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Sterimax Opioid Anesthetics Product Portfolio Table 97. Sterimax Recent Development Table 98. Grunenthal Company Information Table 99. Grunenthal Business Overview Table 100. Grunenthal Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Grunenthal Opioid Anesthetics Product Portfolio Table 102. Grunenthal Recent Development Table 103. Akorn Company Information Table 104. Akorn Business Overview Table 105. Akorn Opioid Anesthetics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Akorn Opioid Anesthetics Product Portfolio Table 107. Akorn Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Opioid Anesthetics Distributors List Table 111. Opioid Anesthetics Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Opioid Anesthetics Product Image Figure 2. Global Opioid Anesthetics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Opioid Anesthetics Sales (2021-2032) & (k tons) Figure 5. Global Opioid Anesthetics Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Opioid Anesthetics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injection Image Figure 11. Global Opioid Anesthetics Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global Opioid Anesthetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Opioid Anesthetics Sales Volume Share by Type (2021-2032) Figure 14. Global Opioid Anesthetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Opioid Anesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Opioid Anesthetics Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Opioid Anesthetics Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 20. Global Opioid Anesthetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Opioid Anesthetics Sales Volume Share by Application (2021-2032) Figure 22. Global Opioid Anesthetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Opioid Anesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Opioid Anesthetics Sales Value Share by Application (2021-2032) Figure 25. Global Opioid Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 26. Global Opioid Anesthetics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Opioid Anesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Opioid Anesthetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 30. North America Opioid Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Opioid Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Opioid Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 36. South America Opioid Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Opioid Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Opioid Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Opioid Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Opioid Anesthetics Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Opioid Anesthetics Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • Janssen
  • Teva
  • Sandoz
  • Merck
  • Mylan
  • Abbvie
  • Sterimax
  • Grunenthal
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Anesthetics Sales Value (2021-2032)
  4. 1.2.2 Global Opioid Anesthetics Sales Volume (2021-2032)
  5. 1.2.3 Global Opioid Anesthetics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Opioid Anesthetics Market Dynamics
  1. 2.1 Opioid Anesthetics Industry Trends
  2. 2.2 Opioid Anesthetics Industry Drivers
  3. 2.3 Opioid Anesthetics Industry Opportunities and Challenges
  4. 2.4 Opioid Anesthetics Industry Restraints
3 Opioid Anesthetics Market by Company
  1. 3.1 Global Opioid Anesthetics Company Revenue Ranking in 2025
  2. 3.2 Global Opioid Anesthetics Revenue by Company (2021-2026)
  3. 3.3 Global Opioid Anesthetics Sales Volume by Company (2021-2026)
  4. 3.4 Global Opioid Anesthetics Average Price by Company (2021-2026)
  5. 3.5 Global Opioid Anesthetics Company Ranking (2024-2026)
  6. 3.6 Global Opioid Anesthetics Company Manufacturing Base and Headquarters
  7. 3.7 Global Opioid Anesthetics Company Product Type and Application
  8. 3.8 Global Opioid Anesthetics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Opioid Anesthetics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Opioid Anesthetics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Opioid Anesthetics Market by Type
  1. 4.1 Opioid Anesthetics Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Opioid Anesthetics Sales Volume by Type
  5. 4.2.1 Global Opioid Anesthetics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Opioid Anesthetics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Opioid Anesthetics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Opioid Anesthetics Sales Value by Type
  9. 4.3.1 Global Opioid Anesthetics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Opioid Anesthetics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Opioid Anesthetics Sales Value Share by Type (2021-2032)
5 Opioid Anesthetics Market by Application
  1. 5.1 Opioid Anesthetics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Opioid Anesthetics Sales Volume by Application
  5. 5.2.1 Global Opioid Anesthetics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Opioid Anesthetics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Opioid Anesthetics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Opioid Anesthetics Sales Value by Application
  9. 5.3.1 Global Opioid Anesthetics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Opioid Anesthetics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Opioid Anesthetics Sales Value Share by Application (2021-2032)
6 Opioid Anesthetics Regional Sales and Value Analysis
  1. 6.1 Global Opioid Anesthetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Anesthetics Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Anesthetics Sales by Region: 2021-2026
  4. 6.2.2 Global Opioid Anesthetics Sales by Region (2027-2032)
  5. 6.3 Global Opioid Anesthetics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Opioid Anesthetics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Opioid Anesthetics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Opioid Anesthetics Sales Value by Region (2027-2032)
  9. 6.5 Global Opioid Anesthetics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Opioid Anesthetics Sales Value (2021-2032)
  12. 6.6.2 North America Opioid Anesthetics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Opioid Anesthetics Sales Value (2021-2032)
  15. 6.7.2 Europe Opioid Anesthetics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Opioid Anesthetics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Opioid Anesthetics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Opioid Anesthetics Sales Value (2021-2032)
  21. 6.9.2 South America Opioid Anesthetics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Opioid Anesthetics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Opioid Anesthetics Sales Value Share by Country, 2025 VS 2032
7 Opioid Anesthetics Country-level Sales and Value Analysis
  1. 7.1 Global Opioid Anesthetics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Opioid Anesthetics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Opioid Anesthetics Sales by Country (2021-2032)
  4. 7.3.1 Global Opioid Anesthetics Sales by Country (2021-2026)
  5. 7.3.2 Global Opioid Anesthetics Sales by Country (2027-2032)
  6. 7.4 Global Opioid Anesthetics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Opioid Anesthetics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Opioid Anesthetics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Opioid Anesthetics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Opioid Anesthetics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Opioid Anesthetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen
  2. 8.1.1 Janssen Company Information
  3. 8.1.2 Janssen Business Overview
  4. 8.1.3 Janssen Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Opioid Anesthetics Product Portfolio
  6. 8.1.5 Janssen Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Opioid Anesthetics Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Opioid Anesthetics Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Opioid Anesthetics Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Opioid Anesthetics Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Abbvie
  32. 8.6.1 Abbvie Company Information
  33. 8.6.2 Abbvie Business Overview
  34. 8.6.3 Abbvie Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Abbvie Opioid Anesthetics Product Portfolio
  36. 8.6.5 Abbvie Recent Developments
  37. 8.7 Sterimax
  38. 8.7.1 Sterimax Company Information
  39. 8.7.2 Sterimax Business Overview
  40. 8.7.3 Sterimax Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sterimax Opioid Anesthetics Product Portfolio
  42. 8.7.5 Sterimax Recent Developments
  43. 8.8 Grunenthal
  44. 8.8.1 Grunenthal Company Information
  45. 8.8.2 Grunenthal Business Overview
  46. 8.8.3 Grunenthal Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Grunenthal Opioid Anesthetics Product Portfolio
  48. 8.8.5 Grunenthal Recent Developments
  49. 8.9 Akorn
  50. 8.9.1 Akorn Company Information
  51. 8.9.2 Akorn Business Overview
  52. 8.9.3 Akorn Opioid Anesthetics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Akorn Opioid Anesthetics Product Portfolio
  54. 8.9.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Anesthetics Value Chain Analysis
  2. 9.1.1 Opioid Anesthetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Anesthetics Sales Mode & Process
  6. 9.2 Opioid Anesthetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Anesthetics Distributors
  9. 9.2.3 Opioid Anesthetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst